Clinical Validation and Implementation of Somatic Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) for Solid Tumors and Hematopoietic Neoplasms.
Associate Professor of Pathology and Laboratory Medicine Dartmouth-Hitchcock Medical Center LEBANON, New Hampshire, United States
Description: This session will provide an overview of clinical validation and implementation of somatic whole exome sequencing (WES) and whole transcriptome sequencing (WTS) for solid tumors and hematopoietic neoplasms.
Learning Objectives: 1. Describe laboratory requirements for the validation of WES 2. Compare and contrast panel testing and WTS for identifying RNA variants
